We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
326
DELISTED
Apellis Pharmaceuticals
APLS
| $31.2M | 0.06% |
342,352
+249,906
| +270% | +$21.6M |
|
327
Elanco Animal Health
ELAN
$11.1B
| $31.1M | 0.06% |
3,096,367
+2,158,367
| +230% | +$20M |
|
328
PUT
Citigroup
C
$226B
| $31.1M | 0.06% |
676,000
-575,500
| -46% | -$27M |
|
329
Envista
NVST
$4.52B
| $31.1M | 0.06% |
917,620
+349,686
| +62% | +$12.3M |
|
|
NOVA
330
DELISTED
Sunnova Energy
NOVA
| $31M | 0.06% |
1,694,284
+1,494,614
| +749% | +$25.3M |
|
331
Insulet
PODD
$9.79B
| $30.8M | 0.06% |
106,885
+88,852
| +493% | +$27M |
|
332
PUT
Chipotle Mexican Grill
CMG
$41.5B
| $30.8M | 0.06% |
720,000
-290,000
| -29% | -$11.5M |
|
333
HealthEquity
HQY
$8.75B
| $30.8M | 0.06% |
487,575
+59,789
| +14% | +$3.47M |
|
|
334
PUT
Advanced Micro Devices
AMD
$789B
| $30.8M | 0.06% |
270,200
+106,200
| +65% | +$11M |
|
335
Flex
FLEX
$44.8B
| $30.7M | 0.06% |
1,476,220
+267,026
| +22% | +$4.76M |
|
336
Gen Digital
GEN
$17.5B
| $30.3M | 0.06% |
+1,634,536
| New | +$28.6M |
|
337
Las Vegas Sands
LVS
$29.6B
| $30.2M | 0.06% |
+521,176
| New | +$30.8M |
|
|
GRMN
338
Garmin
GRMN
$60B
| $30.2M | 0.06% |
289,289
+282,228
| +3,997% | +$28.8M |
|
339
Capri Holdings
CPRI
$1.74B
| $30M | 0.06% |
+836,941
| New | +$33.2M |
|
340
CALL
Berkshire Hathaway Class B
BRK.B
$1.13T
| $30M | 0.06% |
87,900
+23,200
| +36% | +$7.57M |
|
341
JetBlue
JBLU
$2.29B
| $29.9M | 0.06% |
3,376,803
-1,443,120
| -30% | -$10.5M |
|
342
NRG Energy
NRG
$24.8B
| $29.9M | 0.06% |
798,715
+705,809
| +760% | +$24M |
|
343
Silicon Motion
SIMO
$8.68B
| $29.7M | 0.06% |
413,083
-219,438
| -35% | -$14M |
|
|
PDCO
344
DELISTED
Patterson Companies, Inc.
PDCO
| $29.6M | 0.06% |
891,045
+676,473
| +315% | +$18.6M |
|
|
345
CALL
Amazon
AMZN
$2.96T
| $29.6M | 0.06% |
227,300
-56,700
| -20% | -$6.47M |
|
346
DraftKings
DKNG
$11.9B
| $29.6M | 0.06% |
1,114,676
+834,719
| +298% | +$19.2M |
|
347
T. Rowe Price
TROW
$24.3B
| $29.5M | 0.06% |
263,346
-86,876
| -25% | -$9.51M |
|
|
OPRA
348
Opera Ltd
OPRA
$1.79B
| $29.4M | 0.06% |
1,477,432
+1,359,092
| +1,148% | +$19.4M |
|
349
Dick's Sporting Goods
DKS
$18.7B
| $29.3M | 0.06% |
221,925
-13,162
| -6% | -$1.8M |
|
350
Cincinnati Financial
CINF
$27.1B
| $29.3M | 0.06% |
301,423
+108,165
| +56% | +$11.2M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.